Table 3.
aPWV (m/s) | AAD (%/mmHg) | DAD (%/mmHg) | |||||||
---|---|---|---|---|---|---|---|---|---|
β | 95% CI | P | β | 95% CI | P | β | 95% CI | P | |
Sleep efficiency (%) | 0.01 | −0.06 to 0.09 | 0.703 | −0.01 | −0.03 to 0.02 | 0.553 | −0.00 | −0.03 to 0.02 | 0.785 |
WASO (minutes) | 0.01 | −0.00 to 0.03 | 0.135 | −0.00 | −0.01 to 0.00 | 0.968 | 0.00 | −0.01 to 0.01 | 0.942 |
aPWV, aortic pulse wave velocity; AAD, ascending aortic distensibility; DAD, descending aortic distensibility; WASO, wake after sleep onset.
Adjusted for age, gender, race, body mass index, smoking, anti-hypertensive medication use, systolic blood pressure measured at MRI exam, fasting glucose, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, lipid lowering medicine use, left ventricular ejection fraction, and Apnea-Hypopnea index.